Hypothyroidism can pose significant challenges during anesthesia, particularly in pregnant patients, due to the physiological demands of pregnancy on the cardiovascular, respiratory, and endocrine systems. Careful preoperative planning is essential to minimize the risks associated with low thyroid hormone levels and their systemic effects.
Clinical Manifestations Affecting Anesthetic Management
Hypothyroid patients can present with clinical features that influence anesthetic care, including reversible myocardial dysfunction, hypoventilation due to decreased ventilatory drive, obstructive sleep apnea, and increased cerebrospinal fluid (CSF) protein concentration. They may also have anemia, hyponatremia, and abnormal coagulation profiles, increasing perioperative risks. In the context of anesthesia, these patients often have higher peripheral pain thresholds, and there is a tendency toward bradycardia and hypotension under general anesthesia. These factors must be carefully considered when planning anesthetic care, particularly in pregnant women.
Preoperative Management
Before surgery, it is crucial to stabilize patients with severe hypothyroidism. If left untreated, there is a risk of myxedema coma, a life-threatening emergency characterized by hypothermia, altered mental status, and multisystem failure. For pregnant women, optimizing thyroid hormone levels before surgery is essential to avoid complications such as miscarriage, preeclampsia, and preterm labor.
Sedatives and anxiolytics should be used cautiously or avoided due to the heightened sensitivity of hypothyroid patients to their effects, which can result in respiratory depression. Aspiration prophylaxis with an H2 receptor antagonist such as famotidine (ranitidine was withdrawn from the United States market in 2020), a non-particulate antacid, and metoclopramide is safe. Mild to moderate hypothyroidism is not by itself a reason to cancel surgery, and in pregnancy the usual plan is oral levothyroxine optimization without delaying a necessary operation. Severe hypothyroidism or myxedema coma is different: give IV levothyroxine (200 to 400 mcg loading dose, then 50 to 100 mcg daily, lower in older or cardiac patients, with IV liothyronine reserved for the sickest), and give stress-dose hydrocortisone (100 mg IV every 8 hours) before or with the thyroid hormone, because coexisting adrenal insufficiency is possible and thyroid hormone alone can precipitate an adrenal crisis.
Preventing hypothermia during surgery is critical, as hypothyroid patients have impaired thermoregulation. The operating room should be kept warm, and warming devices should be employed to maintain body temperature during and after surgery.
Intraoperative Considerations
Patients with hypothyroidism often have decreased cardiac output, a blunted baroreceptor response, and reduced intravascular volume, making them more sensitive to the depressant effects of anesthetic agents. For these reasons, regional anesthesia is often preferred over general anesthesia in hypothyroid patients. Regional techniques reduce the risk of exacerbating cardiac dysfunction and avoid complications related to airway management.
When general anesthesia is necessary, careful selection and dosing of anesthetic agents are crucial. Hypothyroid patients are more prone to hypotension and bradycardia due to their weakened cardiovascular response. Vasopressors may be needed to maintain blood pressure, though responses to phenylephrine may be reduced, while epinephrine responses remain normal.
Given the potential for abnormal platelet function in hypothyroidism, the risk of epidural hematoma, while theoretical, should be considered. It is essential to confirm normal coagulation status before proceeding with regional anesthesia techniques such as spinal or epidural anesthesia.
Postoperative Management
After surgery, close monitoring is essential to detect hypoventilation, as hypothyroid patients often have blunted respiratory responses and may not adequately compensate for elevated carbon dioxide levels. Hypothermia should be continuously monitored, and proactive management of any residual effects from anesthesia is critical.
If myxedema coma is a concern, prompt thyroid hormone replacement is required, and the patient should be transferred to an intensive care unit (ICU) for comprehensive care, including electrolyte correction and ventilatory support.
By carefully addressing the unique risks of hypothyroidism in both the perioperative and intraoperative periods, anesthesia providers can ensure safe outcomes for these vulnerable patients, particularly during pregnancy.
| Consideration | Hyperthyroidism | Hypothyroidism |
|---|---|---|
| Baseline state | Hypermetabolic; tachycardia, hypertension, arrhythmias, heightened sensitivity to catecholamines | Decreased cardiac output, blunted baroreceptor response, reduced intravascular volume |
| Preoperative goal | Reach a euthyroid state with PTU or methimazole; propranolol for hyperadrenergic symptoms; dexamethasone if antithyroid drugs are not enough | Stabilize severe disease and optimize hormone levels; IV T4 or T3 if severe, with stress-dose hydrocortisone first; mild disease need not delay surgery |
| Premedication | Aspiration prophylaxis, as for every parturient; assess the neck for goiter and tracheal compression; eye protection if exophthalmos | Use sedatives and anxiolytics cautiously or not at all; famotidine, a non-particulate antacid, and metoclopramide are safe choices |
| Preferred technique | Regional; epidural allows gradual sympathetic blockade — avoid spinal on high-dose beta-blockers | Regional, to spare cardiac function and airway management — confirm normal coagulation first |
| If general anesthesia | Agents that minimize sympathetic stimulation (propofol, volatiles); opioids to blunt the intubation response; avoid ketamine, ephedrine, atropine, pancuronium; phenylephrine for hypotension, esmolol for rate | Careful agent selection and dosing; prone to hypotension and bradycardia, vasopressors may be needed |
| Temperature | Prone to hyperthermia; monitor core temperature continuously | Impaired thermoregulation; keep the room warm and actively prevent hypothermia |
| Postoperative focus | Continuous cardiac monitoring for arrhythmias; continue beta-blockers; watch for thyroid storm | Watch for hypoventilation from a blunted response to carbon dioxide; continue monitoring temperature |
